Comparison

EXPAREL® NOW vs Periop Pacemaker

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

EXPAREL® NOW

This medical resource app provides quick access to guidance on using EXPAREL in surgical procedures. It offers information on regional field blocks and nerve blocks, including dosing, neuroanatomy, and probe positioning with ultrasound imagery and video. Content is available offline.

Highlights
  • EXPAREL usage guidance
  • Dosing information
  • Neuroanatomy and probe positioning
  • Ultrasound imagery and video
  • Offline content access
  • Administrative case reports
Read full description

EXPAREL® NOW EXPAREL® (bupivacaine liposome injectable suspension) dosing and regional block resource. EXPAREL® NOW delivers real-time, offline access to bupivacaine liposome dosing, approved nerve block techniques, and regional anesthesia guidance for the OR — EXPAREL® NOW is your trusted clinical companion for postsurgical pain management. Built by Pacira BioSciences, the makers of EXPAREL®. CLINICAL TOOLS AT YOUR FINGERTIPS: • Procedural dosing guidance • Ultrasound-guided probe positioning with full neuroanatomy references • Step-by-step surgical video walkthroughs for regional and field blocks • Complete case reports for clinical decision support • Offline access to all content • For full Prescribing Information, please visit Exparelpro.com DESIGNED FOR HEALTHCARE PROFESSIONALS: From residency to private practice, EXPAREL NOW informs your non-opioid multimodal approach to postsurgical pain management with the clinical depth your team needs. Download free. No login required. Works offline.

About

Periop Pacemaker

This app provides medical professionals with a decision algorithm for managing surgical patients with implantable defibrillators or pacemakers. It is based on guidelines endorsed by the Heart Rhythm Society and updated annually by an expert committee.

Highlights
  • Decision algorithm for pacemaker/defibrillator management
  • Endorsed by Heart Rhythm Society
  • Based on ASA Perioperative Cardiac Implantable Electronic Device Management Aid
  • Annual expert committee updates
  • Designed for medical professionals
Features
Read full description

Periop Pacemaker is a smartphone app that assists medical professionals who take care of surgical patients that have implantable defibrillators or pacemakers. The decision algorithm is endorsed by the Heart Rhythm Society and is based on the American Society of Anesthesiologists Perioperative Cardiac Implantable Electronic Device Management Aid. As device technology evolves, an expert committee of anesthesiologists, cardiologists, and device representatives will meet annually to keep information up-to-date. Disclaimer: ASA Pacemaker is designed for use by medical professionals only. Accessing the app content requires either a one-time payment of $7.99 USD or an annual subscription payment of $2.99 USD. A 30-day free trial is available under the annual subscription plan.

Screenshots

EXPAREL® NOW4 screens
Periop Pacemaker4 screens

Verdict

The call

The clearest difference is in-app purchases: EXPAREL® NOW at none against Periop Pacemaker's 2. Periop Pacemaker's advantage is ratings volume (8 vs 1). On price, rating, review sentiment and update cadence there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Periop Pacemaker sells 2 in-app purchases, starting at $2.99 per year. EXPAREL® NOW asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 5.0 for EXPAREL® NOW against 5.0 for Periop Pacemaker. That said, the two scores are not equally well evidenced: Periop Pacemaker has 8 ratings behind it against 1, so its average is the more settled of the two. Written reviews split almost evenly too, at 100% and 100% positive.

UpkeepUpdate frequency

Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on June 20, 2026 and September 9, 2026 respectively.

Scorecard3 real differences · 7 level
EXPAREL® NOW versus Periop Pacemaker: the parameters behind the verdict, then further details
ParameterEXPAREL® NOWPeriop Pacemaker
PriceFreeFree
Rating5.0 (1 ratings)5.0 (8 ratings)
Positive reviews100.0% of reviews100.0% of reviews
Number of ratings18 — better
Update frequencyEvery 2 monthsEvery 2 months
AdsNoNo
In-app purchasesNo — betterYes
MonetizationFree — betterFree with in-app purchases
DevicesiPhone, iPad, iPod — betteriPhone, iPod
Requires iOS14.013.0 — better
Further details — not scored
Size48 MB43 MB
Age rating17+17+
DeveloperPacira Pharmaceuticals, Inc.Rhythm Management, LLC

Customer experience

EXPAREL® NOW

All ratings1 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

Periop Pacemaker

All ratings8 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews5 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

EXPAREL® NOW

No in-app purchases

2 purchases

Periop Pacemaker

Subscriptions1
  • PERIOP PACEMAKER ANNUAL FEE1 Month trial$2.991 Year
One-time1
  • Periop Pacemaker$7.99

Questions

Is EXPAREL® NOW free?
EXPAREL® NOW is free to download, with no in-app purchases.
Is Periop Pacemaker free?
Periop Pacemaker is free to download, with in-app purchases available.
Which has better reviews, EXPAREL® NOW or Periop Pacemaker?
EXPAREL® NOW and Periop Pacemaker are both rated 5.0 out of 5 on the App Store, from 1 and 8 ratings respectively.
Do EXPAREL® NOW or Periop Pacemaker have ads?
Neither EXPAREL® NOW nor Periop Pacemaker shows ads.
Which is updated more often, EXPAREL® NOW or Periop Pacemaker?
EXPAREL® NOW ships an update every 2 months, and Periop Pacemaker every 2 months. Most recently, EXPAREL® NOW was updated on June 20, 2026 and Periop Pacemaker on September 9, 2026.

Other comparisons